Comparing the efficacy and safety of biportal endoscopic discectomy with microscopic discectomy for lumbar herniated intervertebral disc: a multicentre, prospective, assessor-blinded, randomized controlled trial.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2025;13(13):29 Bone Joint J . 2025 May 1;107-B(5):529-539.What this means for my practice?
BED provides equivalent functional outcomes to MD in treating single-level lumbar disc herniation, with added benefits such as reduced early pain, better scar appearance, and fewer wound complications. This supports its role as a minimally invasive, effective alternative in surgical practice. However, the findings are limited by a short 12-month follow-up and lack of data on analgesic use and long-term outcomes.
Study Summary
One hundred patients with single-level lumbar disc herniation were randomized to receive either biportal endoscopic discectomy (BED; n = 50) or microscopic discectomy (MD; n = 50). The primary outcome of interest was the Oswestry Disability Index (ODI) at 12 months. Secondary outcomes included surgical site pain, scar appearance (POSAS), serum creatine phosphokinase (CPK) ratio, and rates of wound complications. Outcomes were assessed at 2 weeks, 3 months, 6 months, and 12 months. Overall, the results of the study revealed that ODI scores were equivalent between the two groups at 12 months. BED was associated with reduced early postoperative pain, better cosmetic scarring, lower CPK levels, and fewer wound dehiscence events. These findings support BED as a safe and effective alternative to MD, offering added benefits from its minimally invasive approach.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!